Extraterritorial Anti-bribery and Anti-corruption Compliance Requirements – A Third Party Perspective

In Pharmaceutical Compliance Monitor, William Marquardt discusses expectations to comply with extraterritorial anti-bribery and anti-corruption (AB/AC) regulations, and costs associated with these expectations.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s